Role of HER2 in breast cancer (I) - PowerPoint PPT Presentation

1 / 16
About This Presentation
Title:

Role of HER2 in breast cancer (I)

Description:

Role of HER2 in breast cancer (I) HER2 is an oncogene involved in abnormal cell growth HER2 gene amplification or protein overexpression produces activated HER2 ... – PowerPoint PPT presentation

Number of Views:302
Avg rating:3.0/5.0
Slides: 17
Provided by: 78639
Category:
Tags: breast | cancer | her2 | oncogene | role

less

Transcript and Presenter's Notes

Title: Role of HER2 in breast cancer (I)


1
Role of HER2 in breast cancer (I)
  • HER2 is an oncogene involved in abnormal cell
    growth
  • HER2 gene amplification or protein overexpression
    produces activated HER2 receptors, which
    stimulates cell growth

2
Role of HER2 in breast cancer (II)
  • HER2 gene amplification or receptor
    overexpression occurs in approximately 30 of
    metastatic breast cancers
  • HER2-positive tumors are associated with poor
    prognosis and shortened disease-free/overall
    survival

3
INCIDENCE OF RAS GENE MUTATIONS
IN HUMAN CANCER
TUMOR TYPE
INCIDENCE () PANCREATIC
CARCINOMA 90 COLON CARCINOMA 50 THYROID
CARCINOMA 50 LUNG ADENOMA
30 MELANOMA
20 LYMPHOID 10 BLADDER
06
4
(No Transcript)
5
Signal Transduction-Directed Cancer
TreatmentsSausville, et a., 2003. Ann. Rev.
Pharmacol. Toxicol. 43199-231.

6
1960
The Philadelphia chromosome
a causal relationship between the chromosome
abnormality observed and chronic granulocytic
leukemia.
Peter Nowell
Hungerford
7
A specific genetic translocation
1973
Janet Rowley
8
Conversion of abl-protooncogene into an oncogene
in myelogenous leukemia
9
Abelson kinase (Abl)
1980
  • Cytoplasmic protein tyrosine kinase

Bcr-Abl, is an overactive kinase
10
Physiologic Regulation by the Normal ABL Protein
and Deregulation by BCR-ABL
11
Abl BCR-Abl
nucleus, cytoplasm cytoplasm
nuclear Abl is proapoptotic antiapoptotic
regulated kinase deregulated kinase


12
(No Transcript)
13
(No Transcript)
14
STI1571, Gleevec, Glivac, Imatinib
15
(No Transcript)
16
Inhibitors of tyrosine kinases
ZD 1839- Iressa----EGFR non-small cell lung
cancer, Tarceva---erlotinib pancreatic cancer
Write a Comment
User Comments (0)
About PowerShow.com